Edward Humphries
Director - Discovery Biology Maxion Therapeutics
Seminars
Wednesday 23rd September 2026
Panel: Comparing Modality Selection Decisions to Match Biology & Indication Requirements
4:30 pm
- Examining how biology, delivery constraints & safety risk shaped final modality choices
- Weighing durability, tissue access, reversibility & tolerability across competing strategies
- Identifying modality decision principles that remain consistent across CNS & peripheral programs
Wednesday 23rd September 2026
Leveraging Antibody-Toxin Conjugates to Achieve Selective & Functional Ion Channel Modulation
3:30 pm
- Exploiting toxin-derived mechanisms and extracellular epitopes to overcome selectivity challenges in highly conserved ion channel families
- Designing antibody-based ion channel therapeutics that combine functional modulation with improved subtype discrimination
- Translating platform capabilities from in vitro electrophysiology through in vivo preclinical models across multiple therapeutic indications
